Preventing Neonatal Adrenal Crisis in CAH Through Timely 17-OHP Screening

Neonatal adrenal crisis is a life-threatening emergency that can be prevented with early diagnosis and treatment. Congenital adrenal hyperplasia (CAH), especially the salt-wasting form caused by 21-hydroxylase deficiency, is a leading cause of adrenal crisis in newborns. This condition disrupts hormone production, leading to dangerous imbalances in sodium and potassium levels. A recent NICU case highlights how delayed 17-hydroxyprogesterone (17-OHP) screening and missed early diagnosis can result in preventable adrenal collapse. Understanding this case provides valuable lessons for clinicians and caregivers to improve outcomes for affected infants.

Clinical Presentation of Neonatal Adrenal Crisis

A 12-day-old male infant was admitted multiple times to the NICU with symptoms that initially suggested common neonatal conditions such as sepsis or dehydration. The key clinical signs included:

• Repeated vomiting

• Poor feeding and lethargy

• Progressive weight loss

• Hyponatremia (low serum sodium)

• Hyperkalemia (elevated serum potassium)

  
  

Despite treatment with broad-spectrum antibiotics and intravenous fluids, the infant’s condition worsened. Blood cultures remained negative, and supportive care failed to stabilize the baby. These symptoms are classic but nonspecific, often leading to diagnostic delays.

Importance of 17-OHP Measurement in Diagnosis

The turning point came during the third admission when a 17-OHP test was ordered as part of an expanded endocrine evaluation. The results showed severely elevated 17-OHP levels, confirming salt-wasting CAH due to 21-hydroxylase deficiency. This enzyme deficiency prevents the production of cortisol and aldosterone, hormones essential for maintaining electrolyte balance and blood pressure.

Without adequate cortisol, the infant’s body could not respond properly to stress, and aldosterone deficiency caused excessive salt loss. The accumulation of 17-OHP is a hallmark of this disorder and serves as a critical diagnostic marker.

Immediate Treatment and Recovery

Once the diagnosis was confirmed, treatment began immediately with:

• Hydrocortisone to replace glucocorticoids

• Fludrocortisone to provide mineralocorticoid support

  
  

Within hours, the infant’s electrolyte levels normalized, vomiting stopped, and blood pressure stabilized. Follow-up care in the NICU showed no further adrenal crises, and the infant’s clinical condition improved steadily.

Why Early Detection Matters

Salt-wasting CAH typically presents within the first two weeks of life. Early symptoms can mimic other neonatal illnesses, making timely screening essential. Delayed diagnosis increases the risk of adrenal crisis, which can cause severe dehydration, shock, and even death if untreated.

Routine newborn screening programs that include 17-OHP measurement can identify affected infants before symptoms develop. Early detection allows for prompt hormone replacement therapy, preventing adrenal collapse and improving long-term outcomes.

Practical Steps to Prevent Neonatal Adrenal Crisis

Healthcare providers and caregivers can take several steps to reduce the risk of adrenal crisis in newborns with CAH:

• Implement timely newborn screening for 17-OHP, ideally within the first few days of life.

• Educate NICU staff and pediatricians about the signs of adrenal crisis and the importance of early endocrine evaluation.

• Monitor electrolyte levels closely in neonates with unexplained vomiting, poor feeding, or lethargy.

• Initiate hormone replacement therapy immediately upon diagnosis to stabilize the infant.

• Provide family education on recognizing symptoms and managing medication to prevent future crises.

  
  

Final Thoughts

This NICU case underscores the critical role of early 17-OHP screening in preventing neonatal adrenal crisis in infants with CAH. Recognizing the subtle early signs and ordering appropriate endocrine tests can save lives. Healthcare teams should prioritize timely diagnosis and treatment to avoid the severe consequences of adrenal collapse.